Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers
Coussy, F ; El Botty, R ; Lavigne, M ; Gu, C ; Fuhrmann, L ; Briaux, A ; de Koning, L ; Dahmani, A ; Montaudon, E ; Morisset, L ; Huguet, L ; Sourd, L ; Painsec, P ; Chateau-Joubert, S ; Larcher, T ; Vacher, S ; Melaabi, S ; Salomon, A Vincent ; Marangoni, E ; Bieche, I
Journal of hematology and oncology, 2020-02, Vol.13 (1), p.13-10, Article 13 [Periódico revisado por pares]England: BioMed Central Ltd
Texto completo disponível